52750-7
Activated protein C resistance [Presence] in Platelet poor plasma by Coagulation assay
Active
Part Descriptions
LP18494-2 Activated protein C resistance
A hemostatic disorder characterized by a poor anticoagulant response to activated protein C (APC) which increases the risk of a clotting disorder. The activated form of Factor V (Factor Va) is more slowly degraded by activated protein C. Factor V Leiden mutation (R506Q) is the most common cause of APC resistance.
Source: National Library of Medicine, MeSH 2006
LP18494-2 Activated protein C resistance
Activated protein C resistance (APC) has emerged as the most frequent abnormality in patients with idiopathic thrombosis. Patients found to be heterozygous for APC resistence have a seven fold increased risk for venous thrombosis as compared to the general popualtion. Homozygous individuals have an eight fold increased risk of thrombosis. Familial studies and counselling should be considered for positive patients. The activated form of Factor V (Factor Va) is more slowly degraded by activated protein C. Factor V Leiden mutation (R506Q) is the most common cause of APC resistance. Often measured as the ratio of the Appt W APC.
Source: Regenstrief Institute
Fully-Specified Name
- Component
- Activated protein C resistance
- Property
- PrThr
- Time
- Pt
- System
- PPP
- Scale
- Ord
- Method
- Coag
Additional Names
- Short Name
- aPCR PPP Ql
- Display Name
- Activated protein C resistance Coag Ql (PPP)
- Consumer Name Alpha Get Info
- Activated Protein C Resistance, Blood
Example Answer List: LL360-9
Source: Regenstrief InstituteAnswer | Code | Score | Answer ID |
---|---|---|---|
PositiveCopyright http://snomed.info/sct ID:10828004 Positive (qualifier value) | LA6576-8 | ||
NegativeCopyright http://snomed.info/sct ID:260385009 Negative (qualifier value) | LA6577-6 |
Basic Attributes
- Class
- COAG
- Type
- Laboratory
- First Released
- Version 2.24
- Last Updated
- Version 2.73
- Change Reason
- Property changed from Acnc to fit the current LOINC model.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016.
- Order vs. Observation
- Both
- Common Test Rank Get Info
- 17429
Language Variants Get Info
Tag | Language | Translation |
---|---|---|
de-AT | German (Austria) | Synonyms: APC-Resistenz (qual.) |
de-DE | German (Germany) | Aktiviertes-Protein-C-Resistenz: Synonyms: APC-Resistenz |
es-ES | Spanish (Spain) | Resistencia a la proteína C activada: |
es-MX | Spanish (Mexico) | Resistencia a la proteína C activada: |
et-EE | Estonian (Estonia) | Aktiveeritud proteiini C resistentsus: Synonyms: Järgarvuline Juhuslik Trombotsüütidevaene plasma |
fr-CA | French (Canada) | Résistance à la protéine C activée: |
fr-FR | French (France) | Protéine C activée résistance: |
fr-BE | French (Belgium) | Résistance à la protéine C activée: Synonyms: RPCa Test d''Hémostase |
it-IT | Italian (Italy) | Proteina C attivata, resistenza: Synonyms: Plasma povero di piastrine Presenza o Soglia Punto nel tempo (episodio) Resistenza alla proteina C attivata Studio di coagulazione Test di coagulazione |
nl-NL | Dutch (Netherlands) | geactiveerd proteïne C-resistentie: Synonyms: coagulatiemethode |
pt-BR | Portuguese (Brazil) | Resistência a proteína C ativada: Synonyms: ; |
ru-RU | Russian (Russian Federation) | Активированный протеин С резистентность: Synonyms: Анализ факторов свертывания крови; |
tr-TR | Turkish (Turkey) | Aktiflenmiş protein C resistans: Synonyms: Mevcut |
zh-CN | Chinese (China) | 活化蛋白 C 抗性: Synonyms: APC 抗性; |
LOINC Terminology Service (API) using HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
- CodeSystem lookup
- https:
//fhir.loinc.org/CodeSystem/$lookup?system=http: //loinc.org&code=52750-7
Third Party Copyright
This material includes SNOMED Clinical Terms® (SNOMED CT®) which is used by permission of the International Health Terminology Standards Development Organisation (IHTSDO) under license. All rights reserved. SNOMED CT® was originally created by The College of American Pathologists. "SNOMED" and "SNOMED CT" are registered trademarks of the IHTSDO.
This material includes content from the US Edition to SNOMED CT, which is developed and maintained by the U.S. National Library of Medicine and is available to authorized UMLS Metathesaurus Licensees from the UTS Downloads site at https://uts.nlm.nih.gov.
Use of SNOMED CT content is subject to the terms and conditions set forth in the SNOMED CT Affiliate License Agreement. It is the responsibility of those implementing this product to ensure they are appropriately licensed and for more information on the license, including how to register as an Affiliate Licensee, please refer to http://www.snomed.org/snomed-ct/get-snomed-ct or info@snomed.org<mailto:info@snomed.org>. This may incur a fee in SNOMED International non-Member countries.
LOINC Copyright
Copyright © 2024 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright